Identification of hla class i-restricted immunogenic neoantigens in triple negative breast cancer

HIGHLIGHTS

• who: Belu00e9n Aparicio et al. from the Oslo University Hospital, Norway University of Tu00fcbingen, Germany have published the research work: Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer, in the Journal: (JOURNAL)
• what: As a proof of concept, and due to the availability of appropriate experimental tools, the authors focused on HLA-A*02:01-restricted peptides, choosing patients CAM69 and CAM73 as representative . To considering a single HLA class I allele, the studies are focused on SNVs, without including INDELs and other mutations, which have also shown to encode . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.